Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levesque

Showing results (191-200 of 281) with videos related to

Pageof 29
Sort By:
The Journal of Investigative Dermatology|July 1, 2022
Mediators of Capillary-to-Venule Conversion in the Chronic Inflammatory Skin Disease PsoriasisYuliang He, Jihye Kim, Carlotta Tacconi, et al.
Frontiers in Oncology|December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitorsH S Gabryś, L Basler, S Burgermeister, et al.
Cell Death & Disease|December 21, 2024
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosisBenjamin Loos, Adrian Salas-Bastos, Anna Nordin, et al.
Cell Reports|February 9, 2022
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cellsMariela Artola-Borán, Angela Fallegger, Martina Priola, et al.
Melanoma Research|May 17, 2017
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in SwitzerlandJoanna Mangana, Phil F Cheng, Corina Kaufmann, et al.
Cells|March 13, 2024
CD112 Supports Lymphatic Migration of Human Dermal Dendritic CellsNeda Haghayegh Jahromi, Anastasia-Olga Gkountidi, Victor Collado-Diaz, et al.
JCO Precision Oncology|February 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort AnalysisBenedict Gosztonyi, Tarun Mehra, Gabriele Gut, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
Frontiers in Oncology|May 2, 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint InhibitionSimon Burgermeister, Hubert S Gabryś, Lucas Basler, et al.
The Journal of Experimental Medicine|October 28, 2020
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesisMin Ma, Soumitra Ghosh, Daniele Tavernari, et al.
Pageof 29

Showing results (191-200 of 281) with videos related to

Sort By:
Pageof 29
The Journal of Investigative Dermatology|July 1, 2022
Mediators of Capillary-to-Venule Conversion in the Chronic Inflammatory Skin Disease PsoriasisYuliang He, Jihye Kim, Carlotta Tacconi, et al.
Frontiers in Oncology|December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitorsH S Gabryś, L Basler, S Burgermeister, et al.
Cell Death & Disease|December 21, 2024
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosisBenjamin Loos, Adrian Salas-Bastos, Anna Nordin, et al.
Cell Reports|February 9, 2022
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cellsMariela Artola-Borán, Angela Fallegger, Martina Priola, et al.
Melanoma Research|May 17, 2017
Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in SwitzerlandJoanna Mangana, Phil F Cheng, Corina Kaufmann, et al.
Cells|March 13, 2024
CD112 Supports Lymphatic Migration of Human Dermal Dendritic CellsNeda Haghayegh Jahromi, Anastasia-Olga Gkountidi, Victor Collado-Diaz, et al.
JCO Precision Oncology|February 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort AnalysisBenedict Gosztonyi, Tarun Mehra, Gabriele Gut, et al.
Cancers|June 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints TargetedLukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, et al.
Frontiers in Oncology|May 2, 2022
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint InhibitionSimon Burgermeister, Hubert S Gabryś, Lucas Basler, et al.
The Journal of Experimental Medicine|October 28, 2020
Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesisMin Ma, Soumitra Ghosh, Daniele Tavernari, et al.
Pageof 29